BCL2L1 and benign prostatic hyperplasia: As shown in Figure 5A, PGWE or Fi treatments increased not only the ratio of Bax/Bcl-xl but also the protein levels of caspase three and PARP, other factors included in the apoptosis signaling pathway, in prostate tissues of the BPH-induced rats.